Antibody Drug Conjugates

SELECTBIO brings to you its 3rd International conference on ADC Development & Manufacture “Antibodies and Antibody Drug Conjugates” on May 24-25, 2018 in Bengaluru, India.

An innovative therapeutic application which combines the distinctive properties of monoclonal antibodies (mAbs) with the potent cytotoxic effect of small drug molecules is Antibody-drug conjugates or ADCs. This conference will be covering different aspects of ADC development and manufacture, right from the introduction to regulatory thereby ensuring comprehensive understanding of the subject. In addition this event will provide an excellent platform for knowledge sharing, collaborative research and networking with the scientists in the field of Antibody Engineering, Antibody drug conjugates, biopharmaceuticals and Cancer research.

This event is co-located with our International Conference Biomarkers & Diagnostics. Running alongside the conferences will be an exhibition covering the latest advancements in the instrumentation for antibody and cell technologies related research and development.